Authors
Loading...
Retrospective study examines maternal morbidity and fetal outcomes in women with sickle cell disease receiving hydroxyurea, indicating potential benefits.
Desai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: